These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38195245)

  • 1. Evenamide: A Potential Pharmacotherapeutic Alternative for Treatment-Resistant Schizophrenia.
    Singh R; Hahn MK; Bansal Y; Agarwal SM; Remington G
    Int J Neuropsychopharmacol; 2024 Feb; 27(2):. PubMed ID: 38195245
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase 2 Results Indicate Evenamide, A Selective Modulator of Glutamate Release, Is Associated With Clinically Important Long-Term Efficacy When Added to an Antipsychotic in Patients With Treatment-Resistant Schizophrenia.
    Anand R; Turolla A; Chinellato G; Roy A; Hartman RD
    Int J Neuropsychopharmacol; 2023 Aug; 26(8):523-528. PubMed ID: 37349110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultra-Treatment-Resistant Schizophrenia and Clozapine Augmentation.
    Tirupati S
    J Clin Psychopharmacol; 2023 Mar-Apr 01; 43(2):183-184. PubMed ID: 36719407
    [No Abstract]   [Full Text] [Related]  

  • 4. Gut microbiota and treatment-resistant schizophrenia: many questions, fewer answers.
    Manchia M; Squassina A; Tozzi F; Antoniades A; Carpiniello B
    Pharmacogenomics; 2022 Apr; 23(5):277-280. PubMed ID: 35238627
    [No Abstract]   [Full Text] [Related]  

  • 5. Listening to the Patient's Voice: A Patient-Centred Approach to Treatment-Resistant Schizophrenia.
    Ahluwalia A; Rafizadeh R; White RF; Bahji A; Danilewitz M
    Can J Psychiatry; 2022 Mar; 67(3):235-237. PubMed ID: 34889122
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of add-on blonanserin in treatment-resistant schizophrenia therapy: A retrospective cohort study.
    Tang S; Wang S; Feng M; Fang Y; Lv L; Zhao X; Guo P; Yuan Y; Chen H
    Asian J Psychiatr; 2024 Jan; 91():103867. PubMed ID: 38142523
    [No Abstract]   [Full Text] [Related]  

  • 7. Is ECT better than clozapine for treatment-resistant schizophrenia?
    Uppinkudru C; Sreeraj VS; Arumugham SS; Praharaj SK; Goyal N; Sinha P; Thirthalli J
    Asian J Psychiatr; 2023 Dec; 90():103798. PubMed ID: 37871364
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of Treatment-Resistant Schizophrenia in a Patient With Epilepsy With Add on Low-Dose Clozapine-A Case Report.
    Jogi L; Subu O; Jaishankar P; Kumar V
    J Clin Psychopharmacol; 2023 Sep-Oct 01; 43(5):468-469. PubMed ID: 37683242
    [No Abstract]   [Full Text] [Related]  

  • 9. Are serum oxytocin concentrations lower in patients with treatment-resistant schizophrenia?: A 5-year longitudinal study.
    Kanahara N; Nakamura M; Shiko Y; Kawasaki Y; Iyo M
    Asian J Psychiatr; 2022 Oct; 76():103157. PubMed ID: 35551879
    [No Abstract]   [Full Text] [Related]  

  • 10. Insights and improvements: A critical analysis of methodological limitations in the investigation of smoking and valproic acid in treatment-resistant schizophrenia.
    Araujo MB; Nogueira GN; Silveira PLSD; de Souza Júnior SA; de Matos E Souza FG; Bisol LW
    Acta Psychiatr Scand; 2024 Apr; 149(4):361-362. PubMed ID: 38263735
    [No Abstract]   [Full Text] [Related]  

  • 11. Improved response to electroconvulsive therapy after switching from haloperidol to blonanserin in a patient with treatment-resistant schizophrenia.
    Takahashi K; Yokotsuka-Ishida S; Nakamura T; Sasayama D; Washizuka S
    Psychiatry Clin Neurosci; 2022 Mar; 76(3):91-93. PubMed ID: 34921693
    [No Abstract]   [Full Text] [Related]  

  • 12. Precise pharmacogenetic pharmacometabolomic (PPP) guided clozapine therapy in treatment resistant schizophrenia: Insights from one ethnicity experiment.
    Patil AN; Kasudhan KS; Naveen M; Batra GK; Chakrabarti S; Avasthi A; Grover S
    Schizophr Res; 2021 Nov; 237():26-28. PubMed ID: 34481201
    [No Abstract]   [Full Text] [Related]  

  • 13. Thoughts on the Value of Case Series in the Literature: An Example Using the Article on Lurasidone Augmentation of Clozapine in Refractory Schizophrenia.
    Armstrong AG; Preskorn SH
    J Clin Psychopharmacol; 2023 Mar-Apr 01; 43(2):87-88. PubMed ID: 36821468
    [No Abstract]   [Full Text] [Related]  

  • 14. [Argentine consensus on the diagnosis and therapeutics of treatment resistant schizophrenia].
    Corrales A; Vilapriño Duprat M; Benavente Pinto C; Garay C; Corral R; Gargoloff PR; Goldchluk A; Hönig G; Jufe G; Lamaison F; Leiderman EA; Morra C; Rebok F; Gargoloff PD
    Vertex; 2021 Dec; XXXII(154):49-85. PubMed ID: 35041733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment paradigms for treatment-resistant schizophrenia.
    Lim C; Donovan AL
    Lancet Psychiatry; 2024 Jul; 11(7):488-489. PubMed ID: 38879270
    [No Abstract]   [Full Text] [Related]  

  • 16. Genome-wide methylation analysis of treatment resistant schizophrenia.
    De Luca V; Chaudhary Z; Al-Chalabi N; Qian J; Borlido C; Gerretsen P; Graff A; Remington G; Chintoh A
    J Neural Transm (Vienna); 2023 Feb; 130(2):165-169. PubMed ID: 36648581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between subjective distress and symptom domains in patients with treatment-resistant schizophrenia receiving clozapine.
    Tsukahara M; So R; Nomura N; Kitagawa K; Mizuno Y; Misawa F; Kodama M; Uchida H; Mimura M; Takeuchi H
    Schizophr Res; 2022 Feb; 240():228-230. PubMed ID: 35086033
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination of two long-acting injectable antipsychotics in treatment-resistant schizophrenia: A retrospective 12-month mirror-image study.
    Calvin N; Minischetti L; Salanon F; Llorca PM; Pouchon A; Polosan M; Dondé C
    Asian J Psychiatr; 2023 Feb; 80():103402. PubMed ID: 36563612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on novel antipsychotics and pharmacological strategies for treatment-resistant schizophrenia.
    de Bartolomeis A; Ciccarelli M; Vellucci L; Fornaro M; Iasevoli F; Barone A
    Expert Opin Pharmacother; 2022 Dec; 23(18):2035-2052. PubMed ID: 36368055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant improvement of psychotic symptoms in treatment-resistant schizophrenia with clozapine in an adolescent with SHINE syndrome: a case report.
    Yang M; Rubin A; Wondimu R; Grebe T; Ritfeld G
    BMC Psychiatry; 2023 Jun; 23(1):483. PubMed ID: 37386468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.